Lack of pediatric-specific information in monographs of new drugs approved in Canada, study finds

Written by Ilana Landau, Editor

Researchers from McMaster University and McMaster Children’s Hospital (both ON, Canada) have conducted a descriptive analysis of monographs of new drugs approved in Canada from 2007–2016, determining that there is often a lack of important pediatric-specific information in the monographs that perpetuates ‘off-label’ drug use, which may be harmful in this vulnerable population. Pediatric-specific drug information is important and necessary to enable the delivery of optimal pharmacotherapy in children; drug monographs are intended to provide information for healthcare professionals to enable safe and effective drug use. In this new study, researchers from McMaster University and McMaster Children’s Hospital (both ON,...

To view the full article, please register now for access

It's completely free